Adjuvance Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Out of Business

  • Employees
  • 18

Employees

  • Latest Deal Type
  • Out of Business

Adjuvance General Information

Description

Developer of a biopharmaceutical platform designed to improve health and save lives through the development of vaccine adjuvant. The company's platform is based on saponex products that are critical components to many vaccines for multiple indications in infectious disease, oncology, neurobiology, substance abuse, and allergy, enabling patients to improve their immune systems.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 1225 L Street
  • Suite 600
  • Lincoln, NE 68508
  • United States
+1 (212)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 1225 L Street
  • Suite 600
  • Lincoln, NE 68508
  • United States
+1 (212)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Adjuvance Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Out of Business 25-Apr-2026 Completed Out of Business
7. Grant 19-May-2020 Completed Generating Revenue
6. Later Stage VC (Series A1) 29-Jan-2020 Completed Generating Revenue
5. Grant 01-Jan-2020 Completed Generating Revenue
4. Grant 16-Jun-2019 Completed Pre-Clinical Trials
3. Grant 01-Mar-2017 Completed Pre-Clinical Trials
2. Grant 01-Jan-2017 $448K $2.72M Completed Pre-Clinical Trials
1. Seed Round 14-Nov-2016 $2.72M $2.72M Completed Pre-Clinical Trials
To view Adjuvance’s complete valuation and funding history, request access »

Adjuvance Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A-1
Series A-2
To view Adjuvance’s complete cap table history, request access »

Adjuvance Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a biopharmaceutical platform designed to improve health and save lives through the development of vaccine a
Drug Discovery
Lincoln, NE
18 As of 2022

Emeryville, CA
 

Gaithersburg, MD
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Adjuvance Competitors (3)

One of Adjuvance’s 3 competitors is Dynavax Technologies, a Formerly VC-backed company based in Emeryville, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Dynavax Technologies Formerly VC-backed Emeryville, CA
Novavax Corporation Gaithersburg, MD
Glaxosmithkline Biologicals Corporation Saint-Amand-Les-Eaux, France
You’re viewing 3 of 3 competitors. Get the full list »

Adjuvance Patents

Adjuvance Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4429674-A1 Adjuvant compounds and formulations Pending 08-Nov-2021
EP-4429674-A4 Adjuvant compounds and formulations Pending 08-Nov-2021
US-20250025550-A1 Adjuvant compounds and formulations Pending 08-Nov-2021
WO-2023081505-A1 Adjuvant compounds and formulations Inactive 08-Nov-2021
EP-4323377-A1 Vaccines Pending 14-Apr-2021 A61K39/39
To view Adjuvance’s complete patent history, request access »

Adjuvance Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Adjuvance FAQs

  • When was Adjuvance founded?

    Adjuvance was founded in 2009.

  • Where is Adjuvance headquartered?

    Adjuvance is headquartered in Lincoln, NE.

  • What is the size of Adjuvance?

    Adjuvance has 18 total employees.

  • What industry is Adjuvance in?

    Adjuvance’s primary industry is Drug Discovery.

  • Is Adjuvance a private or public company?

    Adjuvance is a Private company.

  • What is Adjuvance’s current revenue?

    The current revenue for Adjuvance is .

  • How much funding has Adjuvance raised over time?

    Adjuvance has raised $22.7M.

  • Who are Adjuvance’s competitors?

    Dynavax Technologies, Novavax, and Glaxosmithkline Biologicals are competitors of Adjuvance.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process